Perceptive Discovery Announces Strategic Expansion Across Radiochemistry, Cell Assay Capabilities, and In Vitro Infrastructure to Strengthen Integrated Preclinical Workflows

Perceptive Discovery, the preclinical and translational services division of Perceptive, today announced a $15M series of strategic investments to expand and enhance its radiochemistry, cell assays, ...
Labroots

[Webinar] In Vitro Assays for T Cell Engagers: From Bench to Data-Driven Decisions

Standard bioassays often fall short when evaluating T cell engagers due to their diverse mechanisms of actions (MOAs) and functional complexity. To generate meaningful preclinical data, ...
The Scientist

Modeling Angiogenesis In Vitro with Tube Formation Assays

Angiogenesis plays a critical role in a wide range of biological processes, including wound healing, reproduction, and cancer. Scientists engaged in angiogenesis drug development research seek ways to ...
News Medical

Microphysiological systems in drug discovery

insights from industryEmily RichardsonLead ScientistCN-BioIn our latest interview, NewsMedical speaks with CN Bio about the translatability between in vitro Organ-on-a-chip (OOC) models, also known as ...
GEN

Advanced In Vitro Screening of New Drugs for Proarrhythmic Activity

Currently, only 10% of the drugs that enter Phase I receive marketing approval from the U.S. Food and Drug Administration (FDA), with unmanageable toxicity accounting for approximately 30% of the ...